Gilead SciencesInc. will allow a subsidiary of the pharmaceutical company Mylan Inc. to have nonexclusive rights to manufacture and distribute its HIV treatment drug in 112 countries.
via WSJ.com: US Business http://ift.tt/1rN67mQ
via WSJ.com: US Business http://ift.tt/1rN67mQ
Nessun commento:
Posta un commento